The 4G/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes

Atherosclerosis
N IwaiM Kinoshita

Abstract

The 4G allele of the plasminogen activator inhibitor (PAI-I) gene is associated with increased PAI-I levels. Increased PAI-I levels have been reported to be associated with atherothrombotic events. However, the significance of the 4G/5G polymorphism of the PAI-I gene in the pathogenesis of ischemic heart diseases has not been determined. We assessed the 4G/5G polymorphism of the PAI-I gene in 500 subjects including 148 normal controls, 23 subjects with normal coronary arteries, 28 subjects with a paradoxical acetylcholine response, 97 subjects with angina pectoris (AP) and 204 subjects with myocardial infarction (MI). We assessed the length of time between the first anginal pain and the onset of acute coronary syndromes (ACS) in the AP and MI subjects. Subjects who developed ACS within 2 months from the first anginal pain were categorized to have a rapid progression to ACS, and subjects who had had stable anginal pain more than 2 months were placed in the non-ACS group. Subjects in the ACS group were younger than those in non-ACS group (P = 0.012) The frequency of the 5G/5G genotype of the PAI-I gene was lower in the ACS (0.228) than in the non-ACS group (0.093) (P = 0.003). Multiple logistic analyses revealed that a younger ag...Continue Reading

References

Jan 23, 1992·The New England Journal of Medicine·V FusterJ H Chesebro
Jan 30, 1992·The New England Journal of Medicine·V FusterJ H Chesebro
Oct 1, 1989·Metabolism: Clinical and Experimental·P CaronP Sié
Aug 1, 1989·Circulation·E Braunwald
Nov 1, 1995·The Journal of Clinical Investigation·D M KerinsD E Vaughan
Jun 1, 1995·Circulation·P Libby
Mar 14, 1995·Proceedings of the National Academy of Sciences of the United States of America·P ErikssonA Hamsten
Oct 1, 1993·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·M CortellaroG Specchia
Apr 1, 1993·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·X C YangG B Phillips

❮ Previous
Next ❯

Citations

Apr 26, 2008·Heart Failure Reviews·Dawood Darbar
Dec 12, 2001·British Journal of Haematology·R F Franco, P H Reitsma
Nov 23, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Mark D SternlichtZena Werb
Feb 27, 2007·Circulation Journal : Official Journal of the Japanese Circulation Society·Masanao NayaNagara Tamaki
Jul 23, 2003·Journal of Thrombosis and Haemostasis : JTH·P J Grant
Mar 16, 2004·British Journal of Haematology·Anton J G Horrevoets
Jun 15, 2007·Journal of Periodontal Research·A A DeCarloP Hardigan
Feb 21, 2008·Journal of Thrombosis and Haemostasis : JTH·M D van der KrabbenC J M Doggen
Jun 17, 2000·Baillière's Best Practice & Research. Clinical Haematology·P J Grant, S E Humphries
Sep 1, 2015·PloS One·Marquitta J WhiteScott M Williams
May 9, 2012·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Vildan Bozok CetintasDemet Cekdemir
Apr 3, 2004·Circulation Research·Dan E ArkingPeter M Spooner
Aug 1, 2006·Pathophysiology of Haemostasis and Thrombosis·Rasaq Olufadi, Christopher D Byrne
Oct 31, 2002·Blood·Johanna G van der BomDiederick E Grobbee
Jun 19, 2019·Journal of Oral Biology and Craniofacial Research·Puja DebnathSrikanta Kumar Rath
Oct 24, 2007·Thrombosis Research·Argirios E TsantesGeorgios Vaiopoulos

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.